secwatch / observer
8-K filed April 19, 2024, 7:59 PM ET CIK 0001460602
regulatory confidence high sentiment negative materiality 0.80

Orgenesis Inc.: Nasdaq/NYSE listing notice — Orgenesis receives Nasdaq delisting notice after restatement reveals stockholders' deficit of $15.4M

Orgenesis Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Orgenesis Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(a)(2), 5550(b)(1), 5810(c)(2)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(a)(2), 5550(b)(1), 5810(c)(2)(A)
Exact text from the filing
000 minimum stockholders’ equity requirement for initial listing on The Nasdaq Capital Market. In addition, the Staff informed the Company that it longer meets the minimum $2,500,000 stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, in accordance with Listing Rule 5550(b)(1). In accordance with Listing Rule 5810(c)(2)(A), the Staff stated that it cannot accept a plan to regain compliance and that as such, this matter is an additional and separate basis for delisting the Company’s securities from The Nasdaq Stock Market. The Staff stated that the Company’s sec
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001493152-24-015330
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.